Abstract

A Non-Stochastic Quadratic Fingerprints-based approach is introduced to classify and design, in a rational way, new antitrypanosomal compounds. A data set of 153 organic-chemicals; 62 with antitrypanosomal activity and 91 having other clinical uses, was processed by a k-means cluster analysis in order to design training and predicting data sets. Afterwards, a linear classification function was derived allowing the discrimination between active and inactive compounds. The model classifies correctly more than 93% of chemicals in both training and external prediction groups. The predictability of this discriminant function was also assessed by a leave-group-out experiment, in which 10% of the compounds were removed at random at each time and their activity a posteriori predicted. Also a comparison with models generated using four well-known families of 2D molecular descriptors was carried out. As an experiment of virtual lead generation, the present TOMOCOMD approach was finally satisfactorily applied on the virtual evaluation of ten already synthesized compounds. The in vitro antitrypanosomal activity of this series against epimastigotes forms of T. cruzi was assayed. The model was able to predict correctly the behaviour of these compounds in 90% of the cases.

Highlights

  • Once an almost exclusively rural disease in Latin America, Chagas’ disease, is undergoing a change in its epidemiological profile due to rising levels of urbanization and migration

  • In the last decades a great number of molecular fingerprints have been presented in the literature.[27,28]

  • Atom-type and total non-stochastic quadratic indices have shown a great ability to encode chemical information, which can be used for the development of QSARs

Read more

Summary

Introduction

Once an almost exclusively rural disease in Latin America, Chagas’ disease, is undergoing a change in its epidemiological profile due to rising levels of urbanization and migration. 4-10 With the use of such design strategies it is possible the handling and screening of large databases in order to find reduced sets of potential new drug candidates.[11,12] the development of computational approaches based on discrimination functions plays an important role, allowing the identification from large chemical libraries of structural subsystems responsible for a property or biological activity, and in this way, the classification of active compounds from inactive ones.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.